- Home
- EYEN vs BUJA Comparison
EYEN vs BUJA Comparison
Compare EYEN & BUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- BUJA
- Stock Information
- Founded
- EYEN 2014
- BUJA 2022
- Country
- EYEN United States
- BUJA Malaysia
- Employees
- EYEN N/A
- BUJA N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- BUJA Blank Checks
- Sector
- EYEN Health Care
- BUJA Finance
- Exchange
- EYEN Nasdaq
- BUJA Nasdaq
- Market Cap
- EYEN 38.2M
- BUJA N/A
- IPO Year
- EYEN 2018
- BUJA 2023
- Fundamental
- Price
- EYEN $0.55
- BUJA $10.96
- Analyst Decision
- EYEN Strong Buy
- BUJA
- Analyst Count
- EYEN 2
- BUJA 0
- Target Price
- EYEN $12.00
- BUJA N/A
- AVG Volume (30 Days)
- EYEN 879.0K
- BUJA 2.7K
- Earning Date
- EYEN 11-11-2024
- BUJA 01-01-0001
- Dividend Yield
- EYEN N/A
- BUJA N/A
- EPS Growth
- EYEN N/A
- BUJA N/A
- EPS
- EYEN N/A
- BUJA 0.29
- Revenue
- EYEN $31,405.00
- BUJA N/A
- Revenue This Year
- EYEN $50,309.30
- BUJA N/A
- Revenue Next Year
- EYEN $421.63
- BUJA N/A
- P/E Ratio
- EYEN N/A
- BUJA $37.13
- Revenue Growth
- EYEN N/A
- BUJA N/A
- 52 Week Low
- EYEN $0.37
- BUJA $10.30
- 52 Week High
- EYEN $2.57
- BUJA $12.18
- Technical
- Relative Strength Index (RSI)
- EYEN 52.60
- BUJA 67.66
- Support Level
- EYEN $0.52
- BUJA $10.85
- Resistance Level
- EYEN $0.59
- BUJA $10.85
- Average True Range (ATR)
- EYEN 0.05
- BUJA 0.00
- MACD
- EYEN 0.01
- BUJA -0.00
- Stochastic Oscillator
- EYEN 66.45
- BUJA 87.50
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About BUJA Bukit Jalil Global Acquisition 1 Ltd.
Bukit Jalil Global Acquisition 1 Ltd is a blank check company.